BioSpace News Archive

Feb. 13, 2020 13:30 UTC BOULDER, Colo.--( BUSINESS WIRE )-- Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its fourth quarter and full year 2019 financial results on Monday, February 24, 2020, after the close of the U.S. financial markets. Clovis’ senior management will host a conference call and live audio webcast at 4:30 p.m. ET to discuss the company’s results in greater detail. The conference call is being webcast and can be accessed from the Clovis Oncology website a

LAVAL, Quebec, Feb. 13, 2020 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate CaPre® (omega-3 phospholipid) for the treatment of severe hypertriglyceridemia (HTG), today announced that it will host a conference call at 1:00 PM Eastern Time on Friday, February 14, 2020 to discuss the Company’s financial results for the third

SAN DIEGO, Feb. 13, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ), a weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, announces that it plans to release its fourth quarter and year-end 2019 financial results before the market opens on Thursday, February 27, 2020 and hold a conference call at 8:30 AM Eastern Time (5:30 AM Pacific Time) to discuss the Company’s financial resu

SARASOTA, Fla. , Feb. 13, 2020 /PRNewswire/ -- INVO Bioscience, Inc. (OTCQB: IVOB) , a medical device company focused on treating infertility with its FDA-cleared INVOcell® product, today announced the appointment of Inger Britt Carlsson , PhD, as the Company’s Vice President of Medical Affairs. Dr. Carlsson will be developing and overseeing INVO Bioscience’s educational sym

- Universities awarded $250,000 research grants as part of the CSL Behring-Science Center Research Acceleration Initiative -

- Fourth straight year in which the prestigious healthcare research firm selects PharmacyKeeper Verification as the No. 1 Category Leader for Intravenous (IV) Workflow Management - PharmacyKeeper Verification is a strategic part of Grifols’ inclusiv® portfolio, offering integrated technology, software and service solutions dedicated to advancing quality and safety in pharmacy operations

Catalyst Biosciences, Inc. announced the pricing of an underwritten public offering of 4,615,385 shares of its common stock, offered at a price of $6.50 per share to the public.

SOUTH JORDAN, Utah, Feb. 13, 2020 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced today that it will release its financial results for the fourth quarter and year ended December 31, 2019, after the close of the stock market on Monday, February 24, 2020. Merit will hold its investor conference call (conference ID 4079914) on the same day (Monda

Persivia, a provider of real-time bundled payment, value based care, population health, and quality management solutions, announced today that its client Prime Healthcare has achieved significant savings under performance year one of BPCI Advanced.

Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the fourth quarter and full year 2019 after market close on Wednesday, February 26, 2020.